Jim Cramer Discusses These 10 Stocks & Says US Faces Unfairly High Tariffs Abroad

5. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Number of Hedge Fund Holders In Q4 2024: 68

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is a biotechnology company that develops drugs for diseases such as cystic fibrosis. Its shares slipped by 15% in December after the firm’s non-opioid pain drug failed to impress investors. Cramer’s previous remarks about Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) expressed disappointment about the drug and added that he saw few catalysts for the firm moving forward. His latest comments are brief:

“Vertex has got revolutionary anti pain drug.”